
Welcome to the first Pancreatic Cancer Webinar Series (PCWS)
Organised by Viatris, in collaboration with the
Pancreatic Society of Great Britain and Ireland (PSGBI)
This is a Viatris promotional webinar series. Products and brands may be mentioned.
Viatris is a new global healthcare company formed from the combination of Mylan and UpJohn, a legacy division of Pfizer.
Improving outcomes for patients with pancreatic cancer is desperately needed. Novel treatment strategies, chemotherapeutic agents and an understanding of the fundamental importance of nutritional failure associated with pancreatic cancer, provides the framework for a multidisciplinary, multimodal approach to improving care. Furthermore, the UK is home to some of the world’s leading pancreatic cancer research experts.
However, there is uncertainty and variation in treatment pathways and not every patient or hospital team may feel the benefit of these improvements. In 2018, the RICOCHET national prospective audit of pancreatic cancer was conducted to determine variation in treatment.
This series of webinars will provide an overview of best practice, and debate where this is unclear, aimed at those clinicians and allied health professionals who treat patients with pancreatic cancer in primary, secondary and tertiary care. Some webinars will coincide with publication of data from the RICOCHET audit to highlight and thank those teams who contributed to this essential body of work.
Webinar dates
Live virtual meetings
Optimal pathways for non metastatic pancreatic cancer
21st January 2021 | 12:00 – 1:00pm
Learning objectives
- Who should be considered for pancreatic resection?
- When to seek a second opinion
- Improving communication between secondary and tertiary centres

Prof Mark Taylor

Prof Giuseppe Kito Fusai

Mr Andrew Smith

Mr Keith Roberts

Mrs Siobhan McKay
Non-surgical and emerging therapies in pancreatic cancer
17th February 2021 | 7:00 – 8:00pm
Learning objectives
- Best practice in pancreatic cancer treatment pathway
- Strategies to increase the delivery of chemotherapy
- Novel and new emerging non-surgical therapies to consider

Mr Sanjay Pandanaboyana

Prof Daniel Palmer
Novel strategies in pancreatic cancer
18th March 2021 | 7:00 – 8:00pm
Learning objectives
- TBC

Speaker TBC

Speaker TBC
Webinars, speakers and learning objectives are subject to change.
Register
This is a promotional webinar series; products and brands may be mentioned. These webinars are initiated, funded and reviewed by Viatris.
Viatris is a new global healthcare company formed from the combination of Mylan and UpJohn, a legacy division of Pfizer.

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Viatris, Building 4, Trident Place, Hatfield Business Park, Mosquito Way, Hatfield, Hertfordshire, AL10 9UL, on phone no. +44 (0) 800 121 8267, email: pv.uk@viatris.com

Job code: NON-2021-0006
January 2021
Chair
Speakers
Mr Keith Roberts
Pancreas surgeon and surgical specialty lead for the Royal College of Surgeons

Prof Juan Valle
Professor and Honorary Consultant in Medical Oncology
Prof Valle has been awarded a number of grants for research leading to a number of high-impact, practice-changing publications and presentations at national and international meetings; he is a peer-reviewer for a number of international medical journals and grant-awarding bodies.

Dr Vikram Mitra
Consultant Gastroenterologist, North Tees Hospital

Vicki Stevenson-Hornby
HPB Cancer Nurse Specialist, Royal Blackburn Hospital
Vicki has proven experience in service improvement for pancreatic cancer patients having worked previously as a HPB Specialist Nurse in Wigan. During her 8 years in post at Wigan, Vicki successfully designed and implemented the nurse-led accelerated jaundice pathway which went on to win the Nursing Times Cancer Nursing Award in 2018. The pathway which was designed by Vicki has been adopted to date, by 8 other NHS Trusts across England.
Vicki went on to receive the Chief Nursing Officer Silver Award in November 2019, this was awarded by Chief Nursing Officer, Ruth May in recognition of Vicki’s commitment and innovative work in service improvement for pancreatic cancer patients.

Dianne Dobson
Specialist Pancreatic Cancer Nurse, Pancreatic Cancer UK

Chair
Prof Mark Taylor
President of PSGBI and HPB Consultant Surgeon, Mater Hospital, Belfast

Speakers
Mr Keith Roberts
Pancreas surgeon and surgical specialty lead for the Royal College of Surgeons

Prof Juan Valle
Professor and Honorary Consultant in Medical Oncology
Prof Valle has been awarded a number of grants for research leading to a number of high-impact, practice-changing publications and presentations at national and international meetings; he is a peer-reviewer for a number of international medical journals and grant-awarding bodies.

Dr Vikram Mitra
Consultant Gastroenterologist, North Tees Hospital

Vicki Stevenson-Hornby
Pancreatic Specialist Nurse, Royal Blackburn Hospital
Vicki has proven experience in service improvement for pancreatic cancer patients having worked previously as a HPB Specialist Nurse in Wigan. During her 8 years in post at Wigan, Vicki successfully designed and implemented the nurse-led accelerated jaundice pathway which went on to win the Nursing Times Cancer Nursing Award in 2018. The pathway which was designed by Vicki has been adopted to date, by 8 other NHS Trusts across England.
Vicki went on to receive the Chief Nursing Officer Silver Award in November 2019, this was awarded by Chief Nursing Officer, Ruth May in recognition of Vicki’s commitment and innovative work in service improvement for pancreatic cancer patients.

Dianne Dobson
Specialist Pancreatic Cancer Nurse, Pancreatic Cancer UK

Prof Enrique Domínguez-Muñoz
Director at the Department of Gastroenterology and Hepatology of the University Hospital of Santiago de Compostela

Mr Richard Wilkin
Academic Clinical Lecturer and General Surgical Registrar in the West Midlands

Prof Mark Taylor
President of PSGBI and HPB Consultant Surgeon, Mater Hospital, Belfast

Prof Giuseppe Kito Fusai
Consultant Surgeon, Specialist in Hepato-pancreato-biliary Surgery
He moved to the UK in 1995 and in 1996 became Fellow of the Royal College of Surgeons of Edinburgh. He specialized in Hepato-pancreato-biliary Surgery and Liver Transplant and he has worked in several Centres of Excellence in the UK and abroad, including Nagoya University Hospital in Japan.
He is a Professor of Surgery at University College London and Consultant Surgeon in HPB Surgery in the Liver Unit at the Royal Free Hospital NHS Trust in London. His primary clinical and academic interest is in pancreatic cancer and neuroendocrine tumours as well as liver metastases and in the modalities to treat patients with advanced disease, including vascular reconstruction. He has published more than 100 peer reviewed publications and he is a member of several societies and committees, including the European Association of HPB surgery (E-AHPBA) and the European Society of Surgical Oncology (ESSO).
He is also the President of the Italian Medical Society of Great Britain and in 2010 he founded “Fiorina”, a charitable fund for the treatment of pancreatic cancer, which to date has supported several clinical and research projects.

Mr Keith Roberts
Pancreas surgeon and surgical specialty lead for the Royal College of Surgeons

Mr Andrew Smith
Consultant surgeon at the Leeds Teaching Hospital Trust
Mr Smith has a busy laparoscopic (keyhole) surgery practice. He performs advanced laparoscopic surgery for gallstones, abdominal wall hernias and hiatus hernias (reflux disease), and laparoscopic surgery for abdominal pain relief. In addition he performs over 80 major pancreas resections per year for pancreatic diseases. He is chairman for pancreatic disease within the Yorkshire Cancer Network. He has an active research programme in benign and malignant pancreatic disease and plays an active role in medical education.

Mrs Siobhan McKay
Academic Clinical Lecturer, University of Birmingham, and HPB Specialty Registrar

Mr Sanjay Pandanaboyana
Consultant HPB surgeon at the Freeman Hospital
He has a strong research portfolio with close to 100 publications and currently hold a position of Associate professor in the University of Auckland, New Zealand and Senior Clinical Lecturer, Newcastle University.
Sanjay has a particular interest in systematic reviews and metaanalysis with more than 30 systematic reviews published on topics related chronic pancreatitis and pancreatic cancer.

Prof Daniel Palmer
North West Cancer Research Fund Professor and Honorary Consultant in Medical Oncology, University of Liverpool

Speaker tbc
Speaker title tbc

Speaker tbc
Speaker title tbc
